Exploring P-gp as moderator of side effects and effectiveness of risperidone in children and adolescents.

Authors :: Hermans RA
Gangapersad RN
Kloosterboer SM
van Schaik RHN
Hillegers MHJ
Koch BCP
de Winter BCM
Dierckx B
Source :: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology [Eur Neuropsychopharmacol] 2024 Aug; Vol. 85, pp. 5-7. Date of Electronic Publication: 2024 Apr 20.
Publication Year :: 2024
Abstract: Competing Interests: Declaration of competing Interest BD, BK, SK and BW received grant research support from The Netherlands Organization for Health Research and Development (ZonMW). RH received grant research support from ZonMW and Stichting de Merel. RG received grant research support from Erasmus Medical Center and Smarter Choices for Better Health. All other authors declare that they have no conflicts of interest.

Subjects :: Humans
Adolescent
Child
ATP Binding Cassette Transporter, Subfamily B, Member 1 metabolism
Male
Female
Treatment Outcome
Risperidone adverse effects
Risperidone therapeutic use
Antipsychotic Agents adverse effects
Antipsychotic Agents therapeutic use

Language :: English
ISSN :: 1873-7862
Volume :: 85
Database :: MEDLINE
Journal :: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Publication Type :: Editorial & Opinion
Accession number :: 38643629
Full Text :: https://doi.org/10.1016/j.euroneuro.2024.04.002

Full Text Access

Tools